Actively Recruiting
Prospective Cohort for Adult Hemophagocytosis
Led by Samsung Medical Center · Updated on 2026-04-24
81
Participants Needed
1
Research Sites
626 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective study enrolls subjects who have clinical and laboratory manifestations related with hemophagocytic lymphohistiocytosis. The purpose of the study is to evaluate clinical and biological features of adult hemophagocytic lymphohistiocytosis. The enrolled subjects into this study will be evaluated according to the HLH (hemophagocytic lymphohistiocytosis)criteria and treated with systemic immunosuppressive therapy or chemotherapy. All subjects will be regularly monitored by physicians participating in this study.
CONDITIONS
Official Title
Prospective Cohort for Adult Hemophagocytosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants must have either hemophagocytosis in tissue or bone marrow or at least three of the eight HLH diagnostic criteria
- Participants must be older than 18 years
- Participants must provide written informed consent
You will not qualify if you...
- Participants who do not meet the inclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Samsung Medical Center
Seoul, South Korea, 135-710
Actively Recruiting
Research Team
S
Seok Jin Kim, MD, PhD
CONTACT
S
Silvia Park, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here